Suvretta Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,370
| Closed | -$2.53M | – | 96 |
|
|
2025
Q1 | $2.53M | Buy |
+9,370
| New | +$2.53M | 0.09% | 72 |
|
|
2024
Q4 | – | Sell |
-13,824
| Closed | -$3.8M | – | 97 |
|
|
2024
Q3 | $3.8M | Sell |
13,824
-23,800
| -63% | -$6.55M | 0.12% | 67 |
|
|
2024
Q2 | $9.14M | Buy |
37,624
+4,964
| +15% | +$1.21M | 0.34% | 51 |
|
|
2024
Q1 | $4.88M | Buy |
32,660
+22,800
| +231% | +$3.41M | 0.18% | 61 |
|
|
2023
Q4 | $1.89M | Buy |
+9,860
| New | +$1.89M | 0.09% | 64 |
|